Skip to main content
Log in

Impaired elimination of caffeine in cirrhosis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The effect of cirrhosis on the disposition and elimination of caffeine was examined. Caffeine (250 mg) was administered orally to 15 healthy controls and eight patients with cirrhosis. The elimination half-life was prolonged from 5.2±2.4 hr (mean±sd) in controls to 6.1±1.9 hr in cirrhotics, although this did not reach statistical significance. The plasma clearance, however, was significantly higher (1.4±0.5 ml/min/kg) in controls as compared to cirrhotics (0.9±0.3 ml/min/kg) (P<0.05). The plasma binding of caffeine was also lower in cirrhotics (31.3±1.8% vs 25.5±4.0%,P<0.01). The plasma clearance of unbound caffeine therefore was reduced from 2.0±0.8 ml/min/kg in controls to 1.2±0.4 ml/min/kg (P<0.01) in cirrhotics, demonstrating impaired elimination of caffeine in cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ritchie JM: Central nervous system stimulants.In The Pharmacological Basis of Therepeutics, 4th ed. LS Goodman and A Gilman (eds). New York, Macmillan, 1970, pp 358–370

    Google Scholar 

  2. Robertson D, Frolich JC Carr RK, Watson JT, Hollifield JW, Shand DG, Oates JA: Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298:181–186, 1978

    Google Scholar 

  3. Bellet S, Kershbaum A, Finck EM: Response of free fatty acids to coffee and caffeine. Metabolism 17:702–707, 1968

    Google Scholar 

  4. Roberts RK, Desmond PV, Schenker S: Drug prescribing in hepatobiliary disease. Drugs 17:198–212, 1979

    Google Scholar 

  5. Mandione A, Imhoff TE, Lee RV, Shum LY, Jusko WJ: Pharmacokinetics of theophylline in hepatic disease. Chest 73:616–622, 1978

    Google Scholar 

  6. Statland BE, Demas T, Danis M: Caffeine accumulation associated with alcoholic liver disease. N Engl J Med 295:110–111, 1976

    Google Scholar 

  7. Demas T, Statland BE: Prolonged half-life on serum caffeine in patients with hepatic insufficiency. Clin Chem 23:1156, 1977

    Google Scholar 

  8. Wilkinson GR, Shand DG: A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–390, 1975

    Google Scholar 

  9. Axelrod J, Rechenthal J: The fate of caffeine in man and a method for its estimation in biological material. J Pharmacol 107:519–523, 1953

    Google Scholar 

  10. Parsons WD, Neims AH: Effect of smoking on caffeine clearance. Clin Pharmacol Ther 26:40–45, 1978

    Google Scholar 

  11. Burg AW: Physiological disposition of caffeine. Drug Metab Rev 4:199–228, 1975

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Medical Research Service of the Veterans Administration and NIH Grant AA00267.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Desmond, P.V., Patwardhan, R.V., Johnson, R.F. et al. Impaired elimination of caffeine in cirrhosis. Digest Dis Sci 25, 193–197 (1980). https://doi.org/10.1007/BF01308138

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308138

Keywords

Navigation